291 related articles for article (PubMed ID: 10732003)
1. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
Infante R; Lahita RG
Geriatrics; 2000 Mar; 55(3):30-2, 35-6, 39-40. PubMed ID: 10732003
[TBL] [Abstract][Full Text] [Related]
2. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis.
Wildy KS; Wasko MC
Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054
[TBL] [Abstract][Full Text] [Related]
3. Treatment advances in rheumatoid arthritis.
Arriola ER; Lee NP
West J Med; 1999 May; 170(5):278-81. PubMed ID: 10379219
[No Abstract] [Full Text] [Related]
4. How is it best to treat early rheumatoid arthritis patients?
O'Dell JR
Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):125-37. PubMed ID: 11358419
[TBL] [Abstract][Full Text] [Related]
5. New drugs for the treatment of rheumatoid arthritis.
Schuna AA; Megeff C
Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.
Luong BT; Chong BS; Lowder DM
Ann Pharmacother; 2000 Jun; 34(6):743-60. PubMed ID: 10860137
[TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitors.
Brooks PM; Day RO
Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
9. New treatments for rheumatoid arthritis.
Pisetsky D
Health News; 1998 Nov; 4(14):3. PubMed ID: 9825708
[No Abstract] [Full Text] [Related]
10. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA; Peterson AN; Doyle J; Huse DM
Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
[TBL] [Abstract][Full Text] [Related]
11. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
Zhao SZ; Wentworth C; Burke TA; Makuch RW
Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
[TBL] [Abstract][Full Text] [Related]
12. New drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 1998 Nov; 40(1040):110-2. PubMed ID: 9844625
[No Abstract] [Full Text] [Related]
13. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
Moride Y; Ducruet T; Rochon S; Lavoie F
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii17-22. PubMed ID: 14585914
[TBL] [Abstract][Full Text] [Related]
14. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
16. Etanercept (Enbrel) -- an update.
Goffe B
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
[TBL] [Abstract][Full Text] [Related]
17. Etanercept and infliximab for rheumatoid arthritis.
Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
[TBL] [Abstract][Full Text] [Related]
18. New and future drug therapies for rheumatoid arthritis.
Simon LS; Yocum D
Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():36-42. PubMed ID: 11001378
[TBL] [Abstract][Full Text] [Related]
19. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
Wolfe F; Michaud K; Burke TA; Zhao SZ
J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
Hochberg MC
Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
